Severe cutaneous drug toxicity following disitamab vedotin treatment for metastatic gastric cancer: a case report
During the use of disitamab vedotin, patients need to be monitored for severe skin toxicity.
Authors
- Luping Zhao (ORCID: https://orcid.org/0000-0002-9439-8683)
- Zhen Cheng (ORCID: https://orcid.org/0000-0001-8197-5560)
- Li Piaopiao
Institutions
- Wenzhou Medical University (CN)
- Dongyang People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-01-16
- DOI
- https://doi.org/10.3389/fonc.2024.1504079
- Citations
- 1
- Primary Topic
- Chemotherapy-related skin toxicity
- Type
- article
- Field-Weighted Citation Impact
- 2.00